STOCK TITAN

[Form 4] AEHR TEST SYSTEMS Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Negative)
Form Type
4

AEHR Test Systems (AEHR) reporting person Erickson Gayn, who serves as President, CEO and a director, reported a non‑derivative transaction dated 10/02/2025 where 439 shares of common stock were withheld to satisfy tax withholding on vested restricted stock units at a price of $32.25. After the withholding, the filing reports 269,153 shares directly beneficially owned and 291,628 shares indirectly beneficially owned through a trust, with the total reported position including unvested restricted stock units and restricted shares. The filing clarifies the withholding was not a sale by the reporting person and discloses the relationship to the issuer as Officer and Director.

AEHR Test Systems (AEHR) persona che segnala Erickson Gayn, che svolge il ruolo di Presidente, CEO e di direttore, ha riferito una transazione non derivativa datata 10/02/2025 in cui sono stati trattenuti 439 azioni ordinarie per soddisfare l'imposta sul ritardo di vesting delle unità azionarie restraintate al prezzo di $32.25. Dopo la ritenuta, la dichiarazione riporta 269,153 azioni direttamente beneficiarie e 291,628 azioni indirectamente beneficiarie tramite una trust, con la posizione totale riportata inclusi unvested restricted stock units e restricted shares. La dichiarazione chiarisce che la trattenuta non è stata una vendita da parte della persona che segnala e divulga la relazione con l'emittente come Dirigente e Direttore.

AEHR Test Systems (AEHR) persona que reporta Erickson Gayn, quien sirve como Presidente, CEO y director, reportó una transacción no derivada fechada el 10/02/2025 en la que se retuvieron 439 acciones comunes para satisfacer la retención de impuestos sobre las unidades de acciones restringidas vestidas a un precio de $32.25. Después de la retención, la declaración reporta 269,153 acciones directamente beneficiosas y 291,628 acciones indirectamente beneficiosas a través de un fideicomiso, con la posición total reportada incluyendo unidades de acciones restringidas no vestidas y acciones restringidas. La declaración aclara que la retención no fue una venta por parte de la persona que reporta y divulga la relación con el emisor como Funcionario y Director.

AEHR Test Systems (AEHR) 보고 담당자 Erickson Gayn사장, CEO 및 이사로 재직하며 10/02/2025에 비파생 거래를 보고했습니다. 상응하는 세금 원천징수를 충족하기 위해 439주의 일반주식이 보류되었고 단가는 $32.25입니다. 보류 후, 제출서는 269,153주의 직접적으로 이익을 보유한 주식과 291,628주의 간접적으로 이익을 보유한 주식이 트러스트를 통해 보유되며, 미귀속된 제한 주식 단위 및 제한 주식을 포함한 총 보유 포지션을 보고합니다. 제출서는 이 보류가 매도가 아니다고 설명하며 발행자와의 관계를 임원 및 이사로 공개합니다.

AEHR Test Systems (AEHR) personne déclarant Erickson Gayn, qui occupe les fonctions de Président, PDG et administrateur, a déclaré une transaction non dérivée datée du 10/02/2025439 actions ordinaires ont été retenues pour satisfaire la retenue d'impôt sur les unités d'actions restreintes acquises, au prix de $32.25. Après la retenue, le dépôt indique 269,153 actions détenues directement de manière bénéficiaire et 291,628 actions détenues indirectement de manière bénéficiaire par le biais d'une fiducie, la position totale déclarée incluant les unités d'actions restreintes non vesting et les actions restreintes. Le dépôt précise que la retenue n'était pas une vente par la personne déclarant et divulgue la relation avec l'émetteur comme Dirigeant et Administrateur.

AEHR Test Systems (AEHR) meldepflichtige Person Erickson Gayn, der als Präsident, CEO und Direktor tätig ist, meldete eine nicht-derivative Transaktion vom Datum 10/02/2025, bei der 439 Stammaktien einbehalten wurden, um die Steuereinbehaltung für vesting Restricted Stock Units zu erfüllen, zu einem Preis von $32.25. Nach dem Einbehalt berichtet die Einreichung 269,153 direkt vorteilhaft gehaltene Aktien und 291,628 indirekt vorteilhaft gehaltene Aktien durch einen Trust, wobei die insgesamt gemeldete Position einschließlich ungevesteter Restricted Stock Units und eingeschränkter Aktien angegeben wird. Die Einreichung klärt, dass der Einbehalt kein Verkauf durch die meldende Person war und macht die Beziehung zum Emittenten als Beamtet und Direktor deutlich.

AEHR Test Systems (AEHR) الشخص المبلغ Erickson Gayn، الذي يشغل مناصب الرئيس، المدير التنفيذي والمدير، قد أبلغ عن صفقة غير مشتقة بتاريخ 10/02/2025 حيث تم حجز 439 سهماً عاديًا لتلبية حجز الضرائب على وحدات الأسهم المقيدة المكتسبة، بسعر $32.25. بعد الحجز، يذكر الملف أن 269,153 سهماً مملوكاً فعلياً بشكل مباشر و 291,628 سهماً مملوكاً بشكل غير مباشر عن طريق صندوق ائتماني، مع وجود الموقف الإجمالي المبلغ عنه شاملاً وحدات الأسهم المقيدة غير المستفيدة والأسهم المقيدة. ويوضح الملف أن الحجز ليس بيعاً من قبل الشخص المبلغ ويكشف عن العلاقة مع المصدر كـ موظف ومدير.

AEHR Test Systems (AEHR) 报告人 Erickson Gayn,任职为 总裁、CEO 及董事,报告了一笔非衍生交易,日期为 10/02/2025,其中用以满足税款预扣的普通股 439 股,价格为 $32.25。扣留后,申报显示直接受益所有 269,153 股,间接受益所有 291,628 股,均通过信托持有,总披露的头寸包括未 vest 的受限股票单位与受限股票。申报还明确说明该扣留 不是出售,并披露与发行人的关系为 高级职员兼董事

Positive
  • Transparent disclosure of tax withholding instead of an open‑market sale clarifies intent and maintains communication with investors
  • Substantial retained ownership: reporting person still holds 269,153 direct shares and 291,628 indirect shares, including unvested awards
Negative
  • Direct holdings decreased by 439 shares due to tax withholding on vested RSUs

Insights

Short tax withholding of vested RSUs reduced direct holdings; position largely unchanged.

The transaction shows 439 shares withheld to satisfy tax on vested restricted stock units rather than an open‑market sale, which is a routine administrative step in equity compensation plans. The report lists 269,153 directly owned shares and 291,628 indirectly held via trust, and notes unvested RSUs and restricted shares remain part of the reported position.

Key dependencies are the vesting schedule and future withholding events; investors may note the reporting person retains a substantial ownership stake. Monitor future Forms 4 for additional vesting, withholding, or open‑market transactions within the next vesting cycles.

Filing indicates compliance with Section 16 reporting and clarifies the nature of the disposition.

The Form 4 records the transaction as a disposition coded F with an explanatory remark that shares were withheld for tax obligations on vesting. That language signals administrative compliance and avoids misinterpretation as a liquidity‑driven sale by management.

Governance implications are limited: ensure ongoing transparency by checking subsequent filings for any sales or additional vesting events tied to executive compensation; such filings typically occur around scheduled vesting dates.

AEHR Test Systems (AEHR) persona che segnala Erickson Gayn, che svolge il ruolo di Presidente, CEO e di direttore, ha riferito una transazione non derivativa datata 10/02/2025 in cui sono stati trattenuti 439 azioni ordinarie per soddisfare l'imposta sul ritardo di vesting delle unità azionarie restraintate al prezzo di $32.25. Dopo la ritenuta, la dichiarazione riporta 269,153 azioni direttamente beneficiarie e 291,628 azioni indirectamente beneficiarie tramite una trust, con la posizione totale riportata inclusi unvested restricted stock units e restricted shares. La dichiarazione chiarisce che la trattenuta non è stata una vendita da parte della persona che segnala e divulga la relazione con l'emittente come Dirigente e Direttore.

AEHR Test Systems (AEHR) persona que reporta Erickson Gayn, quien sirve como Presidente, CEO y director, reportó una transacción no derivada fechada el 10/02/2025 en la que se retuvieron 439 acciones comunes para satisfacer la retención de impuestos sobre las unidades de acciones restringidas vestidas a un precio de $32.25. Después de la retención, la declaración reporta 269,153 acciones directamente beneficiosas y 291,628 acciones indirectamente beneficiosas a través de un fideicomiso, con la posición total reportada incluyendo unidades de acciones restringidas no vestidas y acciones restringidas. La declaración aclara que la retención no fue una venta por parte de la persona que reporta y divulga la relación con el emisor como Funcionario y Director.

AEHR Test Systems (AEHR) 보고 담당자 Erickson Gayn사장, CEO 및 이사로 재직하며 10/02/2025에 비파생 거래를 보고했습니다. 상응하는 세금 원천징수를 충족하기 위해 439주의 일반주식이 보류되었고 단가는 $32.25입니다. 보류 후, 제출서는 269,153주의 직접적으로 이익을 보유한 주식과 291,628주의 간접적으로 이익을 보유한 주식이 트러스트를 통해 보유되며, 미귀속된 제한 주식 단위 및 제한 주식을 포함한 총 보유 포지션을 보고합니다. 제출서는 이 보류가 매도가 아니다고 설명하며 발행자와의 관계를 임원 및 이사로 공개합니다.

AEHR Test Systems (AEHR) personne déclarant Erickson Gayn, qui occupe les fonctions de Président, PDG et administrateur, a déclaré une transaction non dérivée datée du 10/02/2025439 actions ordinaires ont été retenues pour satisfaire la retenue d'impôt sur les unités d'actions restreintes acquises, au prix de $32.25. Après la retenue, le dépôt indique 269,153 actions détenues directement de manière bénéficiaire et 291,628 actions détenues indirectement de manière bénéficiaire par le biais d'une fiducie, la position totale déclarée incluant les unités d'actions restreintes non vesting et les actions restreintes. Le dépôt précise que la retenue n'était pas une vente par la personne déclarant et divulgue la relation avec l'émetteur comme Dirigeant et Administrateur.

AEHR Test Systems (AEHR) meldepflichtige Person Erickson Gayn, der als Präsident, CEO und Direktor tätig ist, meldete eine nicht-derivative Transaktion vom Datum 10/02/2025, bei der 439 Stammaktien einbehalten wurden, um die Steuereinbehaltung für vesting Restricted Stock Units zu erfüllen, zu einem Preis von $32.25. Nach dem Einbehalt berichtet die Einreichung 269,153 direkt vorteilhaft gehaltene Aktien und 291,628 indirekt vorteilhaft gehaltene Aktien durch einen Trust, wobei die insgesamt gemeldete Position einschließlich ungevesteter Restricted Stock Units und eingeschränkter Aktien angegeben wird. Die Einreichung klärt, dass der Einbehalt kein Verkauf durch die meldende Person war und macht die Beziehung zum Emittenten als Beamtet und Direktor deutlich.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Erickson Gayn

(Last) (First) (Middle)
C/O AEHR TEST SYSTEMS
400 KATO TERRACE

(Street)
FREMONT CA 94539

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
AEHR TEST SYSTEMS [ AEHR ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
X Officer (give title below) Other (specify below)
President and CEO
3. Date of Earliest Transaction (Month/Day/Year)
10/02/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 10/02/2025 F 439(1) D $32.25 269,153(2) D
Common Stock 291,628 I By Trust
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Represents shares that were withheld to satisfy tax withholding obligations upon vesting of restricted stock units. This does not represent a sale by the Reporting Person.
2. The amount reported includes shares subject to unvested restricted stock units and unvested restricted shares.
Remarks:
/s/Chris Siu, Attorney-in-Fact 10/09/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Erickson Gayn report on Form 4 for AEHR (AEHR)?

The Form 4 reports that 439 shares of common stock were withheld to satisfy tax withholding on vested restricted stock units; this was recorded as a disposition coded F.

How many AEHR shares does the reporting person own after the transaction?

The filing shows 269,153 shares directly beneficially owned and 291,628 shares indirectly beneficially owned via a trust, with unvested RSUs and restricted shares included in reported amounts.

Was the withheld share event a sale by the reporting person?

No. The filing explicitly states the 439 shares were withheld to satisfy tax withholding obligations upon vesting and did not represent a sale by the reporting person.

What is the transaction price shown for the withheld shares?

The Form 4 lists a price of $32.25 associated with the transaction reported as tax withholding.

What roles does the reporting person hold at AEHR?

The reporting person is identified as both a Director and an Officer (President and CEO).
Aehr Test Sys

NASDAQ:AEHR

AEHR Rankings

AEHR Latest News

AEHR Latest SEC Filings

AEHR Stock Data

774.80M
28.16M
5.31%
60.66%
18.86%
Semiconductor Equipment & Materials
Instruments for Meas & Testing of Electricity & Elec Signals
Link
United States
FREMONT